Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115081) titled 'A multicenter randomized clinical controlled study on comparing the efficacy of intravitreal injection of different doses of ganciclovir in the treatment of cytomegalovirus retinitis' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Chaoyang Hospital, Capital Medical University

Condition: Cytomegalovirus Retinitis

Intervention: Low-dose group:Induction period (two weeks):Inject 0.4 mg/0.1 mL of GCV into the vitreous cavity, twice a week. Maintenance period (four weeks):Inject 0.4 mg/0.1 mL of GCV into the vitreous cavity, once a week.

Recruitment Status: N...